Medindia

X

Halozyme Therapeutics Reports Second Quarter 2010 Financial Results

Friday, August 6, 2010 Corporate News J E 4
Advertisement

Halozyme Therapeutics, Inc.

Condensed Consolidated Balance Sheets

June 30,

December 31,

2010

2009

(unaudited)

ASSETS

Current assets:

Cash and cash equivalents

$  41,312,426

$   67,464,506

Accounts receivable

2,253,771

4,243,909

Inventory

1,081,876

1,159,551

Prepaid expenses and other assets

4,676,229

1,573,777

Total current assets

49,324,302

74,441,743

Property and equipment, net

2,161,549

2,708,016

Total Assets

$  51,485,851

$   77,149,759

LIABILITIES AND STOCKHOLDERS' (DEFICIT) EQUITY

Current liabilities:

Accounts payable

$    2,101,349

$     2,820,491

Accrued expenses

4,134,661

6,083,854

Deferred revenue

4,825,735

5,492,604

Total current liabilities

11,061,745

14,396,949

Deferred revenue, net of current portion

53,857,056

54,989,588

Deferred rent, net of current portion

684,315

859,833

Stockholders' (deficit) equity:

Common stock

92,010

91,682

Additional paid-in capital

181,739,270

178,821,852

Accumulated deficit

(195,948,545)

(172,010,145)

Total stockholders' (deficit) equity

(14,117,265)

6,903,389

Total Liabilities and Stockholders' (Deficit) Equity

$  51,485,851

$   77,149,759

Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Wick'em Bra Liner on NBC's TODAY Show - New Produc...
S
BioSpecifics Technologies Corp. Reports Second Qua...